Inventor · disambiguated record
Aaron Michael Ring
Also filed as: RING AARON · RING AARON M · RING AARON MICHAEL
41 granted patents·18 pending applications·366 citations·filing 2011–2025
97Inventor score
Files withUNIV LELAND STANFORD JUNIOR34UNIV YALE15AB INITIO BIOTHERAPEUTICS INC3VIB VZW3GARCIA KENAN CHRISTOPHER1
Top patents by PatentIndex Score
59 records- 0197US9562087B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Feb 7, 2017·45 cites·30 claims
- 0297US9546206B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jan 17, 2017·33 cites·27 claims
- 0396US11208481B2High affinity SIRP-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Dec 28, 2021·7 cites·28 claims
- 0496US10781256B2Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodiesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Sep 22, 2020·14 cites·14 claims
- 0596US10081680B2Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodiesUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Sep 25, 2018·42 cites·15 claims
- 0696US9845345B2SIRP polypeptide compositions and methods of useAB INITIO BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 19, 2017·44 cites·23 claims
- 0795US9944911B2High affinity Sirp-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Apr 17, 2018·23 cites·15 claims
- 0895US9428567B2Antagonists of interleukin-2 receptorGARCIA KENAN CHRISTOPHER·Filed 2011·Granted Aug 30, 2016·56 cites·18 claims
- 0994US10774125B2SIRP-gamma polypeptide compositions and methods of useAB INITIO BIOTHERAPEUTICS INC·Filed 2017·Granted Sep 15, 2020·10 cites·17 claims
- 1094US10611842B2Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Apr 7, 2020·8 cites·15 claims
- 1194US10316094B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jun 11, 2019·9 cites·17 claims
- 1294US10183980B2Superagonists and antagonists of interleukin-2THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV OFFICE OF THE GENERAL COUNSEL·Filed 2016·Granted Jan 22, 2019·15 cites·33 claims
- 1393US10800830B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 13, 2020·6 cites·17 claims
- 1493US10406179B2Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signalingUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Sep 10, 2019·16 cites·15 claims
- 1593US10150802B2Superagonists, partial agonists and antagonists of interleukin-2UNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Dec 11, 2018·19 cites·26 claims
- 1692US12195532B2High affinity SIRP-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jan 14, 2025·1 cites·10 claims
- 1790US11407801B2SIRP-gamma polypeptide compositions and treatment of cancerAB INITIO BIOTHERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·2 cites·6 claims
- 1889US2025223355A1High affinity sirp-alpha reagents and methods of usingUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 1988US11850276B2Interleukin-18 variants and methods of useSIMCHA IL 18 INC·Filed 2022·Granted Dec 26, 2023·2 cites·31 claims
- 2087US10618976B2SIRP-α agonist antibodyUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Apr 14, 2020·5 cites·7 claims
- 2186US11419897B2Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signalingUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Aug 23, 2022·2 cites·16 claims
- 2285US11117943B2Superagonists and antagonists of interleukin-2UNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Sep 14, 2021·1 cites·19 claims
- 2384US2024174729A1High affinity pd-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 2483US2024325494A1Interleukin-18 variants and methods of useUNIV YALE·Filed 2024·Application pending·0 cites
- 2582US11384131B2Superagonists, partial agonists and antagonists of interleukin-2UNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Jul 12, 2022·1 cites·22 claims
- 2681US12403180B2Interleukin-18 variants and methods of useUNIV YALE·Filed 2023·Granted Sep 2, 2025·0 cites·3 claims
- 2780US12343379B2Interleukin-18 variants and methods of useUNIV YALE·Filed 2022·Granted Jul 1, 2025·0 cites·5 claims
- 2880US12233093B2Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signalingUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Feb 25, 2025·0 cites·17 claims
- 2980US10889649B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jan 12, 2021·2 cites·58 claims
- 3080US10654905B2Method of treating graft versus host disease with an interleukin-2 muteinUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted May 19, 2020·2 cites·15 claims
- 3179US12202873B2Superagonists, partial agonists and antagonists of interleukin-2UNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Jan 21, 2025·0 cites·21 claims
- 3278US2023321192A1Interleukin-18 variants and methods of useUNIV YALE·Filed 2023·Application pending·0 cites
- 3377US12006347B2Superagonists and antagonists of interleukin-2UNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jun 11, 2024·0 cites·27 claims
- 3475US2024374679A1Interleukin-18 mimics and methods of useUNIV YALE·Filed 2024·Application pending·0 cites
- 3573US10829771B2Compositions and methods for expressing polypeptides on the surface of cellsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Nov 10, 2020·1 cites·28 claims
- 3673US2025249042A1Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signalingUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 3772US11814419B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Nov 14, 2023·0 cites·25 claims
- 3872US11459388B2Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistanceUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Oct 4, 2022·0 cites·20 claims
- 3972US11041868B2Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulatorUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jun 22, 2021·0 cites·22 claims
- 4069US2021340249A1Muscarinic acetylcholine receptor binding agents and uses thereofVIB VZW·Filed 2021·Application pending·0 cites
- 4168US2019070262A1Interleukin-18 variants and methods of useUNIV YALE·Filed 2018·Application pending·0 cites
- 4267US10520516B2Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective mannerUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Dec 31, 2019·0 cites·21 claims
- 4365US11718675B2Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapyUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Aug 8, 2023·0 cites·14 claims
- 4465US9880179B2Method for selecting agents that bind to transmembrane receptors in a conformationally selective mannerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jan 30, 2018·0 cites·30 claims
- 4562US12029778B2Interleukin-18 mimics and methods of useUNIV YALE·Filed 2020·Granted Jul 9, 2024·0 cites·32 claims
- 4661US2024342246A1Interleukin-12 variants and methods of useUNIV YALE·Filed 2022·Application pending·0 cites
- 4761US2015368339A1Muscarinic acetylcholine receptor binding agents and uses thereofVIB VZW·Filed 2014·Application pending·0 cites
- 4860US2018222978A1Muscarinic acetylcholine receptor binding agents and uses thereofVIB VZW·Filed 2018·Application pending·0 cites
- 4959US2025188139A1Vegf-c muteins for selective lymphatic stimulationUNIV YALE·Filed 2023·Application pending·0 cites
- 5054US2023407291A1Targeting host-bacteria interactions for the treatment of microbiota-mediated diseasesUNIV YALE·Filed 2021·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →